by Dennis Weissman & Associates, LLC | Nov 26, 2018 | Healthcare
Far more aggressive than anything they expected to see from a Republican Administration, the pharmaceutical industry was blindsided by a proposal by the Trump White House to import some of the price controls imposed by Europe’s single-payer healthcare systems. But...
by Dennis Weissman & Associates, LLC | Aug 29, 2018 | Healthcare
With many tech giants looking for openings to disrupt the healthcare industry, a recent survey of health professionals point to Amazon as the one tech player likely to have the biggest future impact on the healthcare sector. Yet it would foolish to discount the...
by Dennis Weissman & Associates, LLC | Jul 23, 2018 | Healthcare
So whose ox is being gored under the Trump Administration’s blueprint to lower prescription drug prices? Well, if you guessed the powerful and politically well-connected multinational pharmaceutical companies — surprise — you’re wrong! A close...
by Dennis Weissman & Associates, LLC | Jun 25, 2018 | Healthcare
Don’t look now but behemoth Amazon, the largest internet retailer in the world, is already on its way to becoming a disruptive force in health care. Already. Amazon has begun selling medical supplies and equipment in the U.S. and specific medical products globally,...
by Dennis Weissman & Associates, LLC | Jun 18, 2018 | Affordable Care Act, Healthcare
Despite failed attempts over the past year to repeal the Affordable Care Act (ACA), the Trump Administration has moved ahead with administrative changes to dilute the law by allowing for short-term and association health plans that circumvent certain ACA protections...
by Dennis Weissman & Associates, LLC | Mar 21, 2018 | Healthcare
Coming like a shot out the the blue, the Centers for Medicare and Medicaid Centers may have opened up a real hornet’s nest in asking for public input on who should be allowed to perform testing in U.S. laboratories as defined by the Clinical Laboratory Improvement...
